Olema Pharmaceuticals, Inc. (OLMA)
14.08
-0.88
(-5.88%)
USD |
NASDAQ |
Mar 20, 16:00
14.10
+0.02
(+0.14%)
After-Hours: 20:00
Olema Pharmaceuticals EPS Diluted (Quarterly) : -0.5044 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.6934 |
| EyePoint Plc | -0.8143 |
| CytomX Therapeutics, Inc. | -0.1734 |
| Corvus Pharmaceuticals, Inc. | -0.1485 |
| Protagonist Therapeutics, Inc. | -0.6932 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.06M |
| Total Expenses (Quarterly) | 46.06M |
| Enterprise Value | 725.93M |
| Earnings Yield | -13.24% |
| Normalized Earnings Yield | -13.24 |